nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—A2M—mammary gland—lung cancer	0.0476	0.149	CbGeAlD
Bacitracin—IDE—bronchus—lung cancer	0.0339	0.106	CbGeAlD
Bacitracin—A2M—respiratory system—lung cancer	0.0317	0.0994	CbGeAlD
Bacitracin—Carbetocin—OXTR—lung cancer	0.0308	0.972	CrCbGaD
Bacitracin—A2M—epithelium—lung cancer	0.0265	0.083	CbGeAlD
Bacitracin—A2M—bronchus—lung cancer	0.0261	0.0818	CbGeAlD
Bacitracin—IDE—bone marrow—lung cancer	0.0242	0.0756	CbGeAlD
Bacitracin—A2M—trachea—lung cancer	0.0235	0.0734	CbGeAlD
Bacitracin—A2M—cardiac atrium—lung cancer	0.022	0.069	CbGeAlD
Bacitracin—IDE—lung—lung cancer	0.0219	0.0685	CbGeAlD
Bacitracin—A2M—bone marrow—lung cancer	0.0186	0.0582	CbGeAlD
Bacitracin—A2M—lung—lung cancer	0.0169	0.0528	CbGeAlD
Bacitracin—IDE—lymph node—lung cancer	0.015	0.0469	CbGeAlD
Bacitracin—A2M—lymph node—lung cancer	0.0115	0.0361	CbGeAlD
Bacitracin—A2M—Lipoprotein metabolism—APOA1—lung cancer	0.00812	0.0141	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—PPIA—lung cancer	0.00803	0.0139	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFC—lung cancer	0.00796	0.0138	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—ALDOA—lung cancer	0.00796	0.0138	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP11—lung cancer	0.00782	0.0136	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—PPIA—lung cancer	0.00765	0.0133	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFC—lung cancer	0.00759	0.0132	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—ALDOA—lung cancer	0.00759	0.0132	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—CASP3—lung cancer	0.0073	0.0127	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—TF—lung cancer	0.00699	0.0121	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—TF—lung cancer	0.00666	0.0116	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—ALB—lung cancer	0.00644	0.0112	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—APP—lung cancer	0.00623	0.0108	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—APP—lung cancer	0.00594	0.0103	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—BCL2L1—lung cancer	0.0059	0.0102	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—MAPK3—lung cancer	0.00586	0.0102	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—APOA1—lung cancer	0.0054	0.00936	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—COL4A2—lung cancer	0.00504	0.00874	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—IL6R—lung cancer	0.00481	0.00834	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TP53—lung cancer	0.00468	0.00812	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.00463	0.00802	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—SDC4—lung cancer	0.00458	0.00795	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—CD9—lung cancer	0.00453	0.00785	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—ALB—lung cancer	0.00428	0.00742	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—ADAMTS1—lung cancer	0.00393	0.00681	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—GNG11—lung cancer	0.00371	0.00644	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—APOA1—lung cancer	0.00371	0.00643	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PPIA—lung cancer	0.00356	0.00618	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP1—lung cancer	0.00356	0.00617	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—JUN—lung cancer	0.00354	0.00615	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ALDOA—lung cancer	0.00353	0.00613	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFC—lung cancer	0.00353	0.00613	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—APOA1—lung cancer	0.00353	0.00612	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00351	0.00608	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KIF5B—lung cancer	0.00339	0.00588	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—EGF—lung cancer	0.00334	0.0058	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—EGF—lung cancer	0.00319	0.00553	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TF—lung cancer	0.0031	0.00538	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—STAT3—lung cancer	0.00307	0.00532	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—ALB—lung cancer	0.00294	0.00509	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—NCAM1—lung cancer	0.00289	0.00502	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CDH1—lung cancer	0.00286	0.00496	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—MYC—lung cancer	0.00285	0.00494	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—ALB—lung cancer	0.0028	0.00485	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KDM1A—lung cancer	0.00278	0.00483	CbGpPWpGaD
Bacitracin—Azotaemia—Methotrexate—lung cancer	0.00278	0.0384	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—APP—lung cancer	0.00276	0.0048	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP2—lung cancer	0.00275	0.00478	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00273	0.00473	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—PIK3CA—lung cancer	0.00242	0.0042	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CD9—lung cancer	0.00233	0.00405	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CASP3—lung cancer	0.00219	0.0038	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—IL6—lung cancer	0.00214	0.00372	CbGpPWpGaD
Bacitracin—Pain—Pemetrexed—lung cancer	0.00214	0.0296	CcSEcCtD
Bacitracin—Pain—Gefitinib—lung cancer	0.00213	0.0294	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP9—lung cancer	0.00207	0.00359	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AZIN2—lung cancer	0.00206	0.00357	CbGpPWpGaD
Bacitracin—A2M—Metabolism—COL4A3BP—lung cancer	0.00206	0.00357	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFA—lung cancer	0.00202	0.00351	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FGR—lung cancer	0.00202	0.00351	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—AKT1—lung cancer	0.00198	0.00343	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—lung cancer	0.00193	0.00334	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00192	0.00333	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—ITGB1—lung cancer	0.00192	0.00333	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—GNG11—lung cancer	0.00191	0.00332	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00186	0.00323	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PPIA—lung cancer	0.00184	0.00318	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFC—lung cancer	0.00182	0.00316	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ALDOA—lung cancer	0.00182	0.00316	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ATP5H—lung cancer	0.00175	0.00304	CbGpPWpGaD
Bacitracin—Vomiting—Crizotinib—lung cancer	0.00174	0.0241	CcSEcCtD
Bacitracin—Rash—Crizotinib—lung cancer	0.00173	0.0239	CcSEcCtD
Bacitracin—Dermatitis—Crizotinib—lung cancer	0.00173	0.0238	CcSEcCtD
Bacitracin—Albuminuria—Doxorubicin—lung cancer	0.00172	0.0237	CcSEcCtD
Bacitracin—A2M—Hemostasis—PPP2R1B—lung cancer	0.00168	0.00291	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—APOA1—lung cancer	0.00164	0.00285	CbGpPWpGaD
Bacitracin—Nausea—Crizotinib—lung cancer	0.00163	0.0225	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00161	0.00279	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TF—lung cancer	0.0016	0.00277	CbGpPWpGaD
Bacitracin—Vomiting—Pemetrexed—lung cancer	0.00159	0.022	CcSEcCtD
Bacitracin—Vomiting—Gefitinib—lung cancer	0.00158	0.0218	CcSEcCtD
Bacitracin—Rash—Pemetrexed—lung cancer	0.00158	0.0218	CcSEcCtD
Bacitracin—Dermatitis—Pemetrexed—lung cancer	0.00158	0.0218	CcSEcCtD
Bacitracin—Rash—Gefitinib—lung cancer	0.00157	0.0217	CcSEcCtD
Bacitracin—Dermatitis—Gefitinib—lung cancer	0.00157	0.0216	CcSEcCtD
Bacitracin—A2M—Hemostasis—IRF1—lung cancer	0.00156	0.00271	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLBD1—lung cancer	0.00156	0.00271	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00154	0.00266	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	0.0015	0.0026	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP1—lung cancer	0.00149	0.00259	CbGpPWpGaD
Bacitracin—Nausea—Pemetrexed—lung cancer	0.00149	0.0205	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—EGF—lung cancer	0.00148	0.00257	CbGpPWpGaD
Bacitracin—Nausea—Gefitinib—lung cancer	0.00148	0.0204	CcSEcCtD
Bacitracin—A2M—Metabolism—HSD17B10—lung cancer	0.00143	0.00248	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—APP—lung cancer	0.00142	0.00247	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—KDR—lung cancer	0.00141	0.00245	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CKB—lung cancer	0.00133	0.0023	CbGpPWpGaD
Bacitracin—Pain—Vinblastine—lung cancer	0.00132	0.0183	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	0.00132	0.00229	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AXL—lung cancer	0.00131	0.00226	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ALB—lung cancer	0.0013	0.00226	CbGpPWpGaD
Bacitracin—Vomiting—Teniposide—lung cancer	0.00129	0.0178	CcSEcCtD
Bacitracin—Pain—Topotecan—lung cancer	0.00129	0.0177	CcSEcCtD
Bacitracin—Rash—Teniposide—lung cancer	0.00128	0.0177	CcSEcCtD
Bacitracin—Dermatitis—Teniposide—lung cancer	0.00128	0.0176	CcSEcCtD
Bacitracin—Pain—Erlotinib—lung cancer	0.00127	0.0176	CcSEcCtD
Bacitracin—A2M—Metabolism—GSTM2—lung cancer	0.00125	0.00216	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CNDP2—lung cancer	0.00125	0.00216	CbGpPWpGaD
Bacitracin—A2M—Metabolism—MTMR3—lung cancer	0.00121	0.00211	CbGpPWpGaD
Bacitracin—Nausea—Teniposide—lung cancer	0.0012	0.0166	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—CDH1—lung cancer	0.0012	0.00208	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PGAM1—lung cancer	0.00118	0.00205	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—RAF1—lung cancer	0.00118	0.00204	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP2—lung cancer	0.00115	0.002	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	0.00115	0.00199	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ITGB1—lung cancer	0.00114	0.00198	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP2A7—lung cancer	0.00113	0.00196	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SDC4—lung cancer	0.0011	0.00192	CbGpPWpGaD
Bacitracin—Pain—Vinorelbine—lung cancer	0.0011	0.0152	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IL2—lung cancer	0.00106	0.00183	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—COL4A2—lung cancer	0.00102	0.00176	CbGpPWpGaD
Bacitracin—A2M—Metabolism—RRM1—lung cancer	0.00101	0.00174	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA3—lung cancer	0.00101	0.00174	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GIPR—lung cancer	0.000989	0.00172	CbGpPWpGaD
Bacitracin—Vomiting—Vinblastine—lung cancer	0.000984	0.0136	CcSEcCtD
Bacitracin—Vomiting—Topotecan—lung cancer	0.000956	0.0132	CcSEcCtD
Bacitracin—Rash—Topotecan—lung cancer	0.000948	0.0131	CcSEcCtD
Bacitracin—Dermatitis—Topotecan—lung cancer	0.000947	0.0131	CcSEcCtD
Bacitracin—A2M—Metabolism—B4GALT5—lung cancer	0.000946	0.00164	CbGpPWpGaD
Bacitracin—Vomiting—Erlotinib—lung cancer	0.000946	0.0131	CcSEcCtD
Bacitracin—Rash—Erlotinib—lung cancer	0.000938	0.0129	CcSEcCtD
Bacitracin—Dermatitis—Erlotinib—lung cancer	0.000937	0.0129	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—SDC4—lung cancer	0.000924	0.0016	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SRC—lung cancer	0.000922	0.0016	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA4—lung cancer	0.00092	0.0016	CbGpPWpGaD
Bacitracin—Nausea—Vinblastine—lung cancer	0.000919	0.0127	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—CASP3—lung cancer	0.000918	0.00159	CbGpPWpGaD
Bacitracin—Pain—Irinotecan—lung cancer	0.000907	0.0125	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—DUSP3—lung cancer	0.000905	0.00157	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000899	0.00156	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—lung cancer	0.000898	0.00156	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA2—lung cancer	0.000897	0.00156	CbGpPWpGaD
Bacitracin—Nausea—Topotecan—lung cancer	0.000893	0.0123	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—RHEB—lung cancer	0.000887	0.00154	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MMP1—lung cancer	0.000886	0.00154	CbGpPWpGaD
Bacitracin—Desmopressin—PTGS2—lung cancer	0.000885	0.028	CrCbGaD
Bacitracin—Pain—Gemcitabine—lung cancer	0.000883	0.0122	CcSEcCtD
Bacitracin—Nausea—Erlotinib—lung cancer	0.000883	0.0122	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—MMP9—lung cancer	0.000867	0.0015	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA1—lung cancer	0.000865	0.0015	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCC3—lung cancer	0.000855	0.00148	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—MAPK3—lung cancer	0.000849	0.00147	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—APOA1—lung cancer	0.000847	0.00147	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM8—lung cancer	0.000841	0.00146	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AKR1C1—lung cancer	0.000828	0.00144	CbGpPWpGaD
Bacitracin—Pain—Cisplatin—lung cancer	0.000823	0.0114	CcSEcCtD
Bacitracin—Vomiting—Vinorelbine—lung cancer	0.000818	0.0113	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—SKI—lung cancer	0.000815	0.00141	CbGpPWpGaD
Bacitracin—Rash—Vinorelbine—lung cancer	0.000811	0.0112	CcSEcCtD
Bacitracin—Dermatitis—Vinorelbine—lung cancer	0.00081	0.0112	CcSEcCtD
Bacitracin—A2M—Metabolism—UGT1A1—lung cancer	0.000804	0.00139	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GNG11—lung cancer	0.000775	0.00135	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CG—lung cancer	0.000774	0.00134	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000771	0.00134	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—EGF—lung cancer	0.000765	0.00133	CbGpPWpGaD
Bacitracin—Nausea—Vinorelbine—lung cancer	0.000764	0.0105	CcSEcCtD
Bacitracin—Pain—Etoposide—lung cancer	0.000754	0.0104	CcSEcCtD
Bacitracin—Pain—Paclitaxel—lung cancer	0.00074	0.0102	CcSEcCtD
Bacitracin—A2M—Metabolism—ALDOA—lung cancer	0.000738	0.00128	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CREBBP—lung cancer	0.000717	0.00124	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NCOA3—lung cancer	0.000717	0.00124	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PXN—lung cancer	0.000707	0.00123	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000704	0.00122	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	0.000701	0.00122	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCG2—lung cancer	0.000697	0.00121	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ADCY1—lung cancer	0.000697	0.00121	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKR1C1—lung cancer	0.000693	0.0012	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OXTR—lung cancer	0.000693	0.0012	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRP—lung cancer	0.000693	0.0012	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ENO2—lung cancer	0.000684	0.00119	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HPGDS—lung cancer	0.000684	0.00119	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CD—lung cancer	0.00068	0.00118	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PPP2R1B—lung cancer	0.000679	0.00118	CbGpPWpGaD
Bacitracin—Vomiting—Irinotecan—lung cancer	0.000674	0.00931	CcSEcCtD
Bacitracin—A2M—Hemostasis—ALB—lung cancer	0.000671	0.00116	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.00067	0.00116	CbGpPWpGaD
Bacitracin—Rash—Irinotecan—lung cancer	0.000669	0.00923	CcSEcCtD
Bacitracin—Dermatitis—Irinotecan—lung cancer	0.000668	0.00922	CcSEcCtD
Bacitracin—A2M—Metabolism—GSTT1—lung cancer	0.000663	0.00115	CbGpPWpGaD
Bacitracin—Vomiting—Gemcitabine—lung cancer	0.000657	0.00907	CcSEcCtD
Bacitracin—A2M—Metabolism—CYP2A6—lung cancer	0.000656	0.00114	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GCLC—lung cancer	0.000656	0.00114	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000653	0.00113	CbGpPWpGaD
Bacitracin—Rash—Gemcitabine—lung cancer	0.000651	0.00899	CcSEcCtD
Bacitracin—Dermatitis—Gemcitabine—lung cancer	0.000651	0.00898	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—GNG11—lung cancer	0.000648	0.00112	CbGpPWpGaD
Bacitracin—Nausea—Irinotecan—lung cancer	0.00063	0.0087	CcSEcCtD
Bacitracin—Pain—Docetaxel—lung cancer	0.000627	0.00866	CcSEcCtD
Bacitracin—A2M—Metabolism—ENO1—lung cancer	0.000621	0.00108	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000619	0.00107	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFC—lung cancer	0.000617	0.00107	CbGpPWpGaD
Bacitracin—Nausea—Gemcitabine—lung cancer	0.000614	0.00847	CcSEcCtD
Bacitracin—Vomiting—Cisplatin—lung cancer	0.000612	0.00845	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000611	0.00106	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—RAF1—lung cancer	0.000607	0.00105	CbGpPWpGaD
Bacitracin—Rash—Cisplatin—lung cancer	0.000607	0.00838	CcSEcCtD
Bacitracin—Dermatitis—Cisplatin—lung cancer	0.000607	0.00837	CcSEcCtD
Bacitracin—A2M—Hemostasis—PIK3CB—lung cancer	0.000593	0.00103	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ADCY1—lung cancer	0.000583	0.00101	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—AKT1—lung cancer	0.000573	0.000993	CbGpPWpGaD
Bacitracin—Nausea—Cisplatin—lung cancer	0.000572	0.0079	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—PPP2R1B—lung cancer	0.000568	0.000986	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SMARCA4—lung cancer	0.000568	0.000986	CbGpPWpGaD
Bacitracin—Vomiting—Etoposide—lung cancer	0.000561	0.00774	CcSEcCtD
Bacitracin—A2M—Metabolism—CYP2E1—lung cancer	0.000557	0.000967	CbGpPWpGaD
Bacitracin—Rash—Etoposide—lung cancer	0.000556	0.00768	CcSEcCtD
Bacitracin—Dermatitis—Etoposide—lung cancer	0.000556	0.00767	CcSEcCtD
Bacitracin—A2M—Metabolism—NQO1—lung cancer	0.000551	0.000956	CbGpPWpGaD
Bacitracin—Vomiting—Paclitaxel—lung cancer	0.00055	0.00759	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—HSPB1—lung cancer	0.000548	0.000951	CbGpPWpGaD
Bacitracin—Rash—Paclitaxel—lung cancer	0.000545	0.00753	CcSEcCtD
Bacitracin—Dermatitis—Paclitaxel—lung cancer	0.000545	0.00752	CcSEcCtD
Bacitracin—A2M—Hemostasis—IL2—lung cancer	0.000544	0.000944	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTHLH—lung cancer	0.000542	0.00094	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.00054	0.000936	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000535	0.000928	CbGpPWpGaD
Bacitracin—Nausea—Etoposide—lung cancer	0.000524	0.00723	CcSEcCtD
Bacitracin—Nausea—Paclitaxel—lung cancer	0.000514	0.00709	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—ANXA1—lung cancer	0.00051	0.000884	CbGpPWpGaD
Bacitracin—A2M—Metabolism—STK11—lung cancer	0.000497	0.000862	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FLT1—lung cancer	0.000494	0.000856	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—EP300—lung cancer	0.000489	0.000847	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APP—lung cancer	0.000483	0.000838	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOTCH3—lung cancer	0.000483	0.000838	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF9—lung cancer	0.000479	0.000831	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SRC—lung cancer	0.000475	0.000824	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000466	0.000809	CbGpPWpGaD
Bacitracin—Vomiting—Docetaxel—lung cancer	0.000466	0.00644	CcSEcCtD
Bacitracin—A2M—Hemostasis—VEGFA—lung cancer	0.000463	0.000803	CbGpPWpGaD
Bacitracin—Rash—Docetaxel—lung cancer	0.000462	0.00638	CcSEcCtD
Bacitracin—Dermatitis—Docetaxel—lung cancer	0.000462	0.00638	CcSEcCtD
Bacitracin—A2M—Metabolism—GSTP1—lung cancer	0.00046	0.000797	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUNB—lung cancer	0.000457	0.000794	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NRAS—lung cancer	0.000457	0.000793	CbGpPWpGaD
Bacitracin—Pain—Methotrexate—lung cancer	0.000452	0.00624	CcSEcCtD
Bacitracin—A2M—Metabolism—CAT—lung cancer	0.000447	0.000776	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000445	0.000771	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MAPK3—lung cancer	0.000438	0.000759	CbGpPWpGaD
Bacitracin—Nausea—Docetaxel—lung cancer	0.000435	0.00601	CcSEcCtD
Bacitracin—A2M—Metabolism—ABCB1—lung cancer	0.000435	0.000755	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TYMS—lung cancer	0.000427	0.000741	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTM1—lung cancer	0.000422	0.000733	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STK11—lung cancer	0.000415	0.000721	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FOXO3—lung cancer	0.000401	0.000695	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP1A1—lung cancer	0.0004	0.000695	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ERCC2—lung cancer	0.000397	0.000689	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KRAS—lung cancer	0.000393	0.000682	CbGpPWpGaD
Bacitracin—Pain—Doxorubicin—lung cancer	0.000391	0.0054	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—AVP—lung cancer	0.000376	0.000652	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1R—lung cancer	0.000362	0.000627	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CA—lung cancer	0.000361	0.000627	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HES1—lung cancer	0.000355	0.000616	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—lung cancer	0.00035	0.000606	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APOA1—lung cancer	0.000344	0.000596	CbGpPWpGaD
Bacitracin—Vomiting—Methotrexate—lung cancer	0.000336	0.00464	CcSEcCtD
Bacitracin—A2M—Hemostasis—HRAS—lung cancer	0.000334	0.00058	CbGpPWpGaD
Bacitracin—Rash—Methotrexate—lung cancer	0.000333	0.0046	CcSEcCtD
Bacitracin—Dermatitis—Methotrexate—lung cancer	0.000333	0.0046	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000329	0.000571	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB3—lung cancer	0.000325	0.000563	CbGpPWpGaD
Bacitracin—Nausea—Methotrexate—lung cancer	0.000314	0.00433	CcSEcCtD
Bacitracin—A2M—Metabolism—PIK3CG—lung cancer	0.000314	0.000544	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TERT—lung cancer	0.000311	0.00054	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGFR1—lung cancer	0.000302	0.000524	CbGpPWpGaD
Bacitracin—A2M—Metabolism—POMC—lung cancer	0.000299	0.000518	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HIF1A—lung cancer	0.000298	0.000516	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—AKT1—lung cancer	0.000295	0.000512	CbGpPWpGaD
Bacitracin—Vomiting—Doxorubicin—lung cancer	0.000291	0.00402	CcSEcCtD
Bacitracin—A2M—Metabolism—CREBBP—lung cancer	0.000291	0.000504	CbGpPWpGaD
Bacitracin—Rash—Doxorubicin—lung cancer	0.000289	0.00398	CcSEcCtD
Bacitracin—Dermatitis—Doxorubicin—lung cancer	0.000288	0.00398	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—APOA1—lung cancer	0.000287	0.000498	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KDR—lung cancer	0.000285	0.000494	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CD—lung cancer	0.000276	0.000478	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALB—lung cancer	0.000272	0.000472	CbGpPWpGaD
Bacitracin—Nausea—Doxorubicin—lung cancer	0.000272	0.00375	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—APC—lung cancer	0.000262	0.000455	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CG—lung cancer	0.000262	0.000455	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KIT—lung cancer	0.000262	0.000455	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EGF—lung cancer	0.000259	0.00045	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—POMC—lung cancer	0.00025	0.000433	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BRAF—lung cancer	0.000247	0.000428	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL6R—lung cancer	0.000244	0.000422	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CREBBP—lung cancer	0.000243	0.000422	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CB—lung cancer	0.00024	0.000417	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—lung cancer	0.000238	0.000413	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAP2K1—lung cancer	0.000232	0.000403	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CD—lung cancer	0.000231	0.0004	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTEN—lung cancer	0.000208	0.00036	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MDM2—lung cancer	0.000207	0.000358	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RAF1—lung cancer	0.000206	0.000357	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB2—lung cancer	0.000204	0.000353	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MTOR—lung cancer	0.000201	0.000349	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CB—lung cancer	0.000201	0.000349	CbGpPWpGaD
Bacitracin—A2M—Metabolism—EP300—lung cancer	0.000198	0.000344	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL8—lung cancer	0.000193	0.000335	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP3—lung cancer	0.000185	0.000321	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL2—lung cancer	0.000185	0.00032	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCND1—lung cancer	0.00018	0.000312	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—lung cancer	0.00018	0.000311	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—lung cancer	0.000175	0.000303	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN1A—lung cancer	0.000174	0.000302	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTEN—lung cancer	0.000174	0.000301	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EP300—lung cancer	0.000166	0.000287	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SRC—lung cancer	0.000161	0.000279	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—lung cancer	0.000157	0.000272	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STAT3—lung cancer	0.000155	0.000269	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NRAS—lung cancer	0.000155	0.000269	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAPK3—lung cancer	0.000148	0.000257	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CA—lung cancer	0.000147	0.000254	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MYC—lung cancer	0.000144	0.00025	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EGFR—lung cancer	0.000141	0.000245	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KRAS—lung cancer	0.000133	0.000231	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CA—lung cancer	0.000123	0.000213	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AKT1—lung cancer	0.00012	0.000208	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—lung cancer	0.000119	0.000206	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HRAS—lung cancer	0.000113	0.000197	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL6—lung cancer	0.000108	0.000188	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKT1—lung cancer	0.0001	0.000174	CbGpPWpGaD
